Cargando…
Remdesivir, on the road to DisCoVeRy
Autores principales: | Gyselinck, Iwein, Janssens, Wim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439616/ https://www.ncbi.nlm.nih.gov/pubmed/34534513 http://dx.doi.org/10.1016/S1473-3099(21)00559-4 |
Ejemplares similares
-
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
por: Ader, Florence, et al.
Publicado: (2022) -
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
por: Vanden Eynde, Jean Jacques
Publicado: (2021) -
Chronic Obstructive Pulmonary Disease Exacerbations: Do All Roads Lead to Rome?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2022) -
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults
por: Ader, Florence
Publicado: (2020) -
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
por: Ader, Florence, et al.
Publicado: (2022)